Skip to main content

15 June 2025

Last updated: Sunday 15 June 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Commentary: Thought disruption in R&D discovery

Tuesday 27 December 2016

Interviewee/Contributor

Tony Sedgwick

Organisation

Novasecta Ltd

Novacta targets C. difficile the natural way

Wednesday 6 May 2009

Interviewee/Contributor

Tony Sedgwick

Organisation

Novacta Biosystems Ltd

Organisations

Janssen Oncology
Immunocore Holdings Plc and Gadeta BV
MRC Technology
Omnix Medical
Galapagos NV
Immunocore Ltd
Cell Therapy Catapult Ltd
PharmNovo AB
SSquared Consulting
Alpine Institute for Drug Discovery

Interviewees and Contributers

Dr Konrad Glund
Marie Manley and Zina Chatzidimitriadou
Peter Heinrich
Femida Gwadry-Sridhar
Martin Jönsson and Johan Sandin and Märta Segerdahl
Paul Kemp
Neil Miller
Mark Watterson
Jan van de Winkel
Alexander Vos and Sander van Deventer

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form